Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California

(2021) Elena Tsoy et al.   JAMA Neurology

Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

(2020) Reisa A. Sperling et al.   JAMA Neurology

Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment

(2020) Joshua D. Grill et al.   JAMA Neurology

Together We Make the Difference: National Strategy for Recruitment and Participation in Alzheimer’s and Related Dementias Clinical Research

(2020) Cerise L Elliott   ETHNICITY & DISEASE

Racial Differences in Alzheimer’s Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2

(2020) Charles F. Murchison et al.   JOURNAL OF ALZHEIMERS DISEASE

Assessment of Racial Disparities in Biomarkers for Alzheimer Disease

(2019) John C. Morris et al.   JAMA Neurology

Barriers to participation in clinical trials: a physician survey

(2018) A. Mahmud et al.   Current Oncology

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

(2018) Fabio Conforti et al.   LANCET ONCOLOGY

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers

(2017) Jennifer C. Howell et al.   Alzheimers Research & Therapy

Inequalities in dementia incidence between six racial and ethnic groups over 14 years

(2016) Elizabeth Rose Mayeda et al.   Alzheimers & Dementia

Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials

(2016) Joshua D. Grill et al.   NEUROBIOLOGY OF AGING

Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action

(2016) Jaewook Shin et al.   Frontiers in Aging Neuroscience

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled

(2015) Sam S. Oh et al.   PLOS MEDICINE

Alzheimer’s Disease In African Americans: Risk Factors And Challenges For The Future

(2014) Lisa L. Barnes et al.   HEALTH AFFAIRS

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

Effect of study partner on the conduct of Alzheimer disease clinical trials

(2012) J. D. Grill et al.   NEUROLOGY

Testing the Right Target and Right Drug at the Right Stage

(2011) R. A. Sperling et al.   Science Translational Medicine

Beyond Diversity to Inclusion

(2010) Peggye Dilworth-Anderson et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Recruitment of a Community-based Cohort for Research on Diversity and Risk of Dementia

(2010) Ladson Hinton et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Challenges and Opportunities

(2010) Edna L. Ballard et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic SyndromeAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

(2008) Jackson T. Wright   ARCHIVES OF INTERNAL MEDICINE

Recruitment of a racially and ethnically diverse sample into a physical activity efficacy trial

(2008) Georita M Frierson et al.   Clinical Trials